FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA), as a type II membrane-bound peptidase, found mainly in prostate tissues [59], and it is regarded as a functional cancer biomarker because it is abundantly upregulated on prostate carcinoma cells and on the neovasculature of most other solid tumors [60].